THOMAS A. KEUER

Corporate Board Profile

Tech Score: 0/100

Oruka Therapeutics, Inc.

Filing Date	Source Excerpt
2018-09-20	The following table sets forth certain information regarding the ownership of the Companys Common Stock as of the August 31, 2018, by: (i) each director and nominee for director, (ii) each of our named executive officers, (iii) all executive officers and directors of the Company as a group, and (iv) all those known by the Company to be beneficial owners of more than five percent of its Common Stock.
2024-10-18	Named Executive Officers and Directors: Thomas A. Keuer

Filing Date

Source Excerpt

2018-09-20

The following table sets forth certain information regarding the ownership of the Companys Common Stock as of the August 31, 2018, by: (i) each director and nominee for director, (ii) each of our named executive officers, (iii) all executive officers and directors of the Company as a group, and (iv) all those known by the Company to be beneficial owners of more than five percent of its Common Stock.

2024-10-18

Named Executive Officers and Directors: Thomas A. Keuer

Data sourced from SEC filings. Last updated: 2026-02-03